Dec 14, 2020 1:27AM EST Credit: REUTERS/Andreas Gebert BERLIN, Dec 14 (Reuters) - Germany's CureVac CVAC.O announced on Monday that it … Adding to the attraction, Hanes has kept up its regular stock dividend, maintaining the payout at 15 cents per common share, for all of 2020. CureVac had its initial public offering on the New York Nasdaq in August 2020. Vice President Communications, CureVac, Tübingen, Germany Zacks Equity Research 12/15/2020 03:43 AM ET CureVac (CVAC) Begins Pivotal Study on COVID-19 Vaccine CureVac (CVAC) doses the first patient in a pivotal study on … Vom vedea ce impozit pe dividende trebuie sa plateasca SRL-ul catre o persoana fizica cu calitatea de angajat. CureVac plans to initiate the pivotal Phase 2b/3 clinical study before end of 2020. Hier erhalten Sie eine Übersicht über die Dividendenzahlung und Dividendenrendite von CUREVAC sowie die anstehenden und vergangenen Hauptversammlungstermine (HV-Termine). Examples include discussion of the company’s strategies, financing plans, growth opportunities and market growth. In analiza de mai jos, avem un SRL din Romania care doreste sa distribuie dividende in luna aprilie 2020. CureVac had its initial public offering on the New York Nasdaq in August 2020. In June 2020, the German Federal Ministry of Economics and Energy announced its commitment to invest 300 million Euros in CureVac through the Kreditanstalt für Wiederaufbau (KfW). Currently, the shares are at $106.64, down 8.24 percent from the previous close of $116.22. © 2021, Nasdaq, Inc. All Rights Reserved. Vice President Investor Relations, CureVac, Tübingen, Germany On Monday, the company has announced the enrollment of the first participant in the pivotal Phase 2b/3 study of its mRNA vaccine candidate, CVnCoV, against COVID-19. Many of these risks are outside of the company’s control and could cause its actual results to differ materially from those it thought would occur. CureVac has also entered into collaborations with multinational corporations and organizations, including Boehringer Ingelheim, Genmab, CRISPR Therapeutics, the Bill & Melinda Gates Foundation, CEPI and others. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges. Fareva, a family-owned company whose strength lies in its financial independence, is one of the world’s leading CDMOs in the pharmaceuticals, cosmetics, make-up, and industrial and homecare fields. Based on its proprietary technology, the company has built a deep clinical pipeline across the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. )+[a-z]{2,63}/i);}, failureMessage: "Value must not contain any URL's"});field5.add(Validate.Presence, {failureMessage:"This field is required"});field5.add(Validate.Length, {tooShortMessage:"Invalid length for field value", tooLongMessage: "Invalid length for field value", minimum: 4, maximum: 4});function handleFormSubmit(ele) { var submitButton = ele.querySelector('input[type=submit]'); var spinner = document.createElement('span'); spinner.setAttribute('class', 'loader'); submitButton.setAttribute('disabled', true); submitButton.style.cursor = 'wait'; submitButton.parentNode.appendChild(spinner); return true; }function resetSubmitButton(e){ var submitButtons = e.target.form.getElementsByClassName('submit-button'); for(var i=0;i